Growth after heart transplantation

Pediatric Transplantation

Volumn 8, Issue 2, 2004, Pages 97-100

  Hathout, Eba H ^a,b   Chinnock, Richard E ^a,b,c  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

^c Northern California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RAPAMYCIN; RECOMBINANT GROWTH FACTOR; TACROLIMUS; THYMOCYTE ANTIBODY;

BONE GROWTH; CHILD GROWTH; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; EDITORIAL; GINGIVA HYPERPLASIA; GRAFT REJECTION; GROWTH DISORDER; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH INHIBITION; HEART DEVELOPMENT; HEART TRANSPLANTATION; HEART WEIGHT; HUMAN; LONG TERM CARE; OSTEOPENIA; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; RISK FACTOR; SHORT STATURE; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

CHILD; CHILD NUTRITION PHYSIOLOGY; GLUCOCORTICOIDS; GROWTH; HEART TRANSPLANTATION; HUMAN GROWTH HORMONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 1942423193     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-3046.2003.00147.x     Document Type: Editorial

References (24)

1. BAUM D, BERNSTEIN D, STARNES VA, et al. Pediatric heart transplantation at Stanford: results of a 15-year experience. Pediatrics 1991: 88: 203.
2. AU J, GREGORY JW, COLQUHOUN IW, et al. Paediatric cardiac transplantation with steroid-sparing maintenance immunosuppression. Arch Dis Child 1992: 67: 1262.
3. CHINNOCK R, BAUM M. Somatic growth in infant heart transplant recipients. Pediatr Transplant 1998: 2: 30.
4. KELLY DA. Nutritional factors affecting growth before and after liver transplantation. Pediatr Transplant 1997: 1: 80.
5. FINE RN. Growth following solid-organ transplantation. Pediatr Transplant 2002: 6: 47.
6. TONSHO B, MEHLS O. Interactions between glucocorticoids and the growth hormone-insulin-like growth factor axis. Pediatr Transplant 1997: 1: 183.
7. HOLT RI, BAKER AJ, JONES JS, MIELL JP. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation. Pediatr Transplant 1998: 2: 76.
8. MAES M, SOKAL E, OTTE JB. Growth factors in children with end-stage liver disease before and after liver transplantation: a review. Pediatr Transplant 1997: 1: 171.
9. TONSHO B, MEHLS O. Factors affecting growth and strategies for treatment in children after renal transplantation. Pediatr Transplant 1997: 1: 176.
10. SALERNO M, BALESTRIERI B, MATRECANO E, et al. Abnormal GH receptor signaling in children with idiopathic short stature. J Clin Endocrinol Metab 2001: 86: 3882.
11. FINE RN, STABLEIN D, COHEN AH, TEJANI A, KOHAUT E. Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 2002: 62: 688.
12. MABUCHI M, KAWAMURA I, TAKESHITA S, et al. Insulin-like growth factor-I enhances choleretic action of FK506 in rats. Transplant Proc 2003: 35: 1596.
13. LU SK, CALLAHAN SM, BRUNNER LJ. Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levels. J Pharmacol Exp Ther 2003: 305: 331.
14. VESCOVI P, MELETI M, MANFREDI M, BONANINI M. Pathogenesis of cyclosporine induced gingival overgrowth. Minerva Stomatol 2003: 52: 219.
15. FINCKENBERG P, INKINEN K, AHONEN J, et al. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 2003: 163: 355.
16. SHULMAN DI, ROOT AW, DIAMOND FB, BERCU BB, MARTINEZ R, BOUCEK RJ Jr. Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency. J Clin Endocrinol Metab 2003: 88: 4095.
17. BRAUNER R, LE HARIVEL DE GONNEVILLE A, KINDERMANS C, et al. Parathyroid function and growth in 22q11.2 deletion syndrome. J Pediatr 2003: 142: 504.
18. MOWAT DR, WILSON MJ, GOOSSENS M. Mowat-Wilson syndrome. J Med Genet 2003: 40: 305.
19. MUSANTE L, KEHL HG, MAJEWSKI F, et al. Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-faciocutaneous syndrome. Eur J Hum Genet 2003: 11: 551.
20. MAFFEI P, MUNNO V, MARSHALL JD, SCANDELLARI C, SICOLO N. The Alstrom syndrome: is it a rare or unknown disease? Ann Ital Med Int 2002: 17: 221.
21. LANE AH, AIJAZ N, GALVIN-PARTON P, LANMAN J, MANGANO R, WILSON TA. Mosaic variegated aneuploidy with growth hormone deficiency and congenital heart defects. Am J Med Genet 2002: 110: 273.
22. MUSEBECK J, MOHNIKE K, BEYE P, et al. Short stature homeobox-containing gene deletion screening by fluorescence in situ hybridisation in patients with short stature. Eur J Pediatr 2001: 160: 561.
23. BOLANOWSKI M, LOMNA-BOGDANOV E, KOSMALA W, et al. Turner's syndrome followed by acromegaly in the third decade of life: an unusual coincidence of two rare conditions. Gynecol Endocrinol 2002: 16: 331.
24. KAWAUCHI M, GUNDRY SR, BAILEY LL. Infant and pediatric heart transplantation: Loma Linda experience. Kyobu Geka 1991: 44: 748.